Ocumetics Technology Corp (TSE:OTC) has released an update.
Ocumetics Technology Corp. has announced the successful creation of a novel intraocular lens that adapts to the eye’s muscle movements, enhancing focus from near to distant objects. This development marks a significant step towards the company’s goal of revolutionizing vision enhancement technology, with the first human implantation expected in early 2025.
For further insights into TSE:OTC stock, check out TipRanks’ Stock Analysis page.
